Chen, X., Wang, C., Tang, Y., Sun, H., Liu, H., Lin, C., Yuan, Z. (2025). Sintilimab plus lenvatinib in combination with transarterial chemoembolization and subsequent radiofrequency ablation for unresectable hepatocellular carcinoma: a single-arm, single-center study. Scientific Reports. https://doi.org/10.1038/s41598-025-12858-y